TY - JOUR AU - Araki, Kazuhiro AU - Miyoshi, Yasuo PY - 2018 TI - Abundant options to avoid toxicity and alternative strategies for human epidermal growth factor receptor 2-positive and hormone receptor-positive advanced breast cancer JF - Translational Cancer Research; Vol 7, Supplement 4 (April 26, 2018): Translational Cancer Research Y2 - 2018 KW - N2 - Clinical oncology has progressed in elucidating multiple aspects for cancer chemotherapy. For most malignancies, we now face many therapeutic options to discuss with patients with cancer. Optimal chemotherapy-sparing regimens are preferable for patients with breast cancer. UR - https://tcr.amegroups.org/article/view/20384